Subunit vaccine

  • Coronavirus (Covid-19)

    Plant-based Baiya vaccine can be adjusted for Omicron variant

    Baiya Phytopharm says that the plant-based Covid-19 vaccine they have been developing in Thailand can be adjusted to be effective against the Omicron variant. The vaccine is currently in the middle of the human trials phase of testing and the Chief Technology Officer says the vaccine formula can be modified to fight Omicron. Baiya has developed a genetically engineered tobacco…

  • Coronavirus (Covid-19)

    Thai-made subunit Covid-19 vaccine gets ok for human trials

    Approval was received to begin testing on human subjects in September for a Covid-19 subunit vaccine created in Thailand by the Vaccine Research Centre of Chulalongkorn University and Baiya Phytopharm Company. The vaccine is the second to be racing to clear testing phases and be used to fight Covid-19 in Thailand. The other, an mRNA vaccine, is being developed by…

  • Coronavirus Vaccines

    Thai start up’s “Subunit” vaccine almost ready for production/use in mid 2022

    The government has announced that a new Covid vaccine may be ready for “production” as early as a couple of weeks. The new vaccine, the “Subunit vaccine” comes from plant protein and uses the same technology as Novavax. Novavax, as reported back in March has previously been shown to be 100% effective at preventing serious illness, hospitalisation or death from…